Head to head
Marex Group vs Morgan Stanley
Side-by-side on the measures that matter, with a plain-English read. Full detail: MRX · MS
MRX
Marex Group
71.88-3.18%
1-year price shape — +158% over the period
Quant Rating B · 97/100
vs
MS
Morgan Stanley
189.71-0.69%
1-year price shape — +24% over the period
Quant Rating D · 64/100
1-year performance, rebased to 100
Morgan Stanley edges it on the scoreable measures. Morgan Stanley pays the highest dividend yield; Morgan Stanley earns the most per share.
| MRX | MS | |
|---|---|---|
| Snapshot | ||
| Sector | Capital Markets | -- |
| Last price | 71.88 | 189.71 |
| Change today | -3.18% | -0.69% |
| 1-year return | +158.1% | +24.4% |
| Market cap | $5.17B | $297.95B |
| 52-week range | 29.41 – 79.11 | 148.51 – 230.98 |
| Valuation | ||
| P/E (TTM) | 13.36 | 15.32 |
| P/E percentile, own 5-yr range | 84th | 46th |
| P/B | 2.76 | 2.80 |
| Dividend yield | 0.85% | 2.11% |
| Profitability & growth | ||
| EPS (TTM) | 3.86 | 10.21 |
| Net profit (TTM) | $277.65M | $16.04B |
| Revenue (TTM) | $5.17B | $73.05B |
| Revenue growth (YoY) | +34.0% | +27.4% |
| Gross margin | 46.5% | -- |
| Operating margin | 32.4% | -- |
| Net margin | 9.4% | 26.8% |
| Free cash flow (TTM) | -- | $-18.58B |
| Ownership & sentiment | ||
| Institutional ownership | 86.7% | 87.0% |
| Insider activity (12mo) | 10 buy / 28 sell | 23 buy / 27 sell |
| Short interest (% of float) | 3.5% | 0.9% |
| Analyst consensus | 100% buy (4) | 62% buy / 38% hold (13) |
| Analyst price target | $87 (+20%) | $241 (+27%) |
| StockVane view | ||
| StockVane Quant Rating | B (97) | D (64) |
| Company | ||
| Employees | 3,282 | 83,000 |
| Founded | 2005 | 1924 |
▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.